English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

This six-month cohort study analyzed the impact of pharmacy interventions ( PI ) on drug-related problems ( DRPs ), blood pressure ( BP ), and quality of life ( QoL ) among patients with stage 5 chronic kidney disease ( CKD ) (n = 83) admitted to Pirngadi Hospital, Medan, Indonesia period February to July 2021.  DRPs ,  BP , and  QoL  of the patients were analyzed before and after  PI .  DRPs  were analyzed applying PCNE version 9,  BP  scores were extracted from the patients’ medical records. Their  QoL  was assessed using a WHOQoL questionnaire. The impacts of  PI  on the incidence of  DRPs ,  BP , and the patients’  QoL  were analyzed applying Wilcoxon Signed Rank and Friedman test in the SPSS program version 23.0. The number of  DRPs  was significantly reduced from 470 before  PI  to 162 following  PI  (p = 0.000). The patients’  QoL  improved significantly from 40 ± 9.87 before  PI  to 69 ± 12. 45 after  PI , p = 0.000.  PI  is crucial to improve the outcomes of  CKD  patients.

pharmacia

﻿The role of pharmacists’ interventions in improving drug-related problems, blood pressure, and quality of life of patients with stage 5 chronic kidney disease

﻿The role of pharmacists’ interventions in improving drug-related problems, blood pressure, and quality of life of patients with stage 5 chronic kidney disease

The role of pharmacists’ interventions in improving drug-related problems, blood pressure, and quality of life of patients with stage 5 chronic kidney disease